1FW2 fundamentals
An in-depth look to WUXI BIOLOGICS (CAYMAN) INC. operating, investing, and financing activities
1FW2 free cash flow for H2 23 is 34.89 M EUR. For 2023, 1FW2 free cash flow was 57.36 M EUR and operating cash flow was 598.33 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM